Bntx stocks.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Dec 13, 2022 · Get the latest BioNTech SE (BNTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. According to 13 stock analysts, the average 12-month stock price forecast for BioNTech SE stock is $146.46, which predicts an increase of 47.34%. The lowest target is $99 and the highest is $216. On average, analysts rate BioNTech SE stock as a buy.BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.

609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... BioNTech ADRs drop after JPMorgan lowers outlook to "underweight". Investing.com -- U.S.-listed shares in BioNTech (NASDAQ:BNTX) dipped in early trading on Friday after analysts at JPMorgan ...

US09075V1026. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2 ...

BNTX After-Hours Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of ...5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Nov 28, 2023 · BioNTech SE (BNTX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioNTech SE | Nasdaq: BNTX | Nasdaq Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings: According to 6 analyst offering 12-month price targets in the last 3 months, BioNTech has an average ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), like BioNTech SE (NASDAQ:BNTX), and AbbVie Inc. (NYSE:ABBV), is a highly popular biotech stock today, as evidenced by the number of hedge funds ...

Get the latest BioNTech SE (BNTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole.Average Volume (3M) 692.88K. Market Cap. $23.63B. Enterprise Value $9.96B. Total Cash (Recent Filing) €13.88B. Total Debt (Recent Filing) €212.20M. Price to Earnings (P/E) 8.5. Beta 0.70. Next Earnings.Jan 21, 2022 2:19AM EST. BioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Track Better Therapeutics Inc (BTTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsIts product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. BNTX - BioNTech SE ADR - Stock screener for investors and traders, financial ...

BNTX: BioNTech SE - Stock Price, Quote and News - CNBCWelcome to our investor page. Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. BNTX - BioNTech SE ADR - Stock screener for investors and traders, financial ...Over the past 3 months, 5 analysts have published their opinion on BioNTech (NASDAQ:BNTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a ...BNTX Real-Time Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and ...

BioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 ...Welcome to our investor page. Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid …

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.BNTX Buy Updated on: 16/11/2023. Financial Health. Healthy . Debt to equity ratio: Neutral ... We did not find social sentiment data for this stock. Analyst Ratings. Analyst / firm Rating; Goldman Sachs: Buy: Mani Foroohar Leerink Partners: Sell: Andrew Ang UBS: Buy: Matthew HarrisonBioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...BioNTech SE BNTX is expected to report its fourth-quarter 2022 results later this month. BioNTech's earnings surprise history has been decent so far, having surpassed expectations in three of the ...8.04. Market cap. 23.49bn USD. EPS (TTM) 12.30. USD. Data delayed at least 15 minutes, as of Nov 24 2023 18:00 GMT. Latest BioNTech SE (BNTX:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... Now, BNTX stock is currently looking at gains of over 400% in the past year. Could it still have room to run this year? Well, for one thing, the company’s work in the coronavirus vaccine field ...

8.04. Market cap. 23.49bn USD. EPS (TTM) 12.30. USD. Data delayed at least 15 minutes, as of Nov 24 2023 18:00 GMT. Latest BioNTech SE (BNTX:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

2 days ago

BNTX: BioNTech SE - Stock Price, Quote and News - CNBC BNTX stock currently hovers slightly below $170, up 45% over the past 12 months. The stock price has declined 24.5% YTD. Shares are trading at 4.9 times forward earnings and 2.5 times trailing sales.The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the ...BNTX After-Hours Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of ...The consensus among . 4 Wall Street analysts covering (NASDAQ: BNTX) stock is to Strong Buy BNTX stock. Out of 4 analysts , 2 ( 50% ) are recommending BNTX as a Strong Buy, 1 ( 25% ) are recommending BNTX as a Buy, 1 ( 25% ) are recommending BNTX as a Hold, 0 ( 0% ) are recommending BNTX as a Sell, and 0 ( 0% ) are recommending BNTX as a Strong ...BioNTech (NASDAQ:BNTX), the partner of Pfizer (NYSE:PFE) for the blockbuster COVID vaccine Comirnaty is on track to introduce a COVID-19 shot adjusted for currently dominant strains in line with ...3 Wall Street analysts have issued twelve-month price objectives for Better Therapeutics' stock. Their BTTX share price targets range from $3.00 to $9.00. On average, they predict the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 2,791.6% from the stock's current price.According to the issued ratings of 10 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $153.69 with a high price target of $260.00 and a low price target of $111.00. What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 29, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.

Now, BNTX stock is currently looking at gains of over 400% in the past year. Could it still have room to run this year? Well, for one thing, the company’s work in the coronavirus vaccine field ...About BioNTech SE ADR. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac ...Apple Inc. Common Stock. $179.24 -0.12 -0.07%. Find the latest Earnings Report Date for BioNTech SE American Depositary Share (BNTX) at Nasdaq.com. Instagram:https://instagram. intuit softwareshare price baiduamam stockbest broker for shorting Jun 18, 2023 · BNTX Stock Assessment. Per Seeking Alpha, BioNTech's stock assessment reveals a mixed bag of results. In terms of valuation, the company is rated "A+" with forward-looking non-GAAP P/E at 20.76 ... roll royce stockkratos defense and security solutions Shares of vaccine maker BioNTech ( BNTX -1.00%) were down 2.8% early Monday afternoon after falling as much as 6.4% earlier in the day. The decline came after the biotech company reported fourth ...Based on analysts offering 12 month price targets for BNTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . fidelity margin rate Spot Bitcoin ETF Hopes Lifted by SEC Move. Lucy Brewster | Nov 30, 2023. Our BNTX ETF report shows the ETFs with the most BNTX exposure, the top performing BNTX ETFs, and most popular BNTX ETF ...BioNTech (NASDAQ:BNTX) is scheduled to announce Q2 earnings results on Monday, August 7th, before market open.The consensus EPS Estimate is -$0.82 and the consensus Revenue Estimate is $797.44M ...